FDA approves new vaccine for smallpox

Share this article:

The FDA has approved a new vaccine against smallpox which could be quickly made if the virtually extinct virus were to reappear.

The vaccine, ACAM2000 is made by Acambis of Cambridge, England and Cambridge, MA. It is intended to inoculate those at high risk of exposure to smallpox and could be used to protect individuals and populations during a bioterrorist attack. 

The federal Centers for Disease Control and Prevention has already stockpiled 192.5 million doses of the vaccine.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.